Showing results (71-80 of 344) with videos related to

Sort By:
Pageof 35
Journal of Intensive Medicine|May 21, 2026
Identifying dynamic antithrombin Ⅲ trajectories to predict clinical outcomes in intra-abdominal sepsisYuteng Ma, Yini Sun, Chaoyang Wang, et al.
Frontiers in Pharmacology|August 30, 2024
Screening of potential antioxidant bioactive Q-markers of paeoniae radix rubra based on an integrated multimodal strategyHengli Li, Yu Zhao, Jiaqi Wang, et al.
Translational Lung Cancer Research|March 15, 2021
Comprehensive evaluation of the clinical utility of plasma EGFR test in non-small cell lung cancer patients with acquired resistance to first-line EGFR inhibitorsHongsik Kim, Hyun Ae Jung, Se-Hoon Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 17, 2024
Survival benefit in EGFR-wild and ALK negative NSCLC patients who participate in clinical trials compared to standard-of-care: Propensity-matched analysisHyun Ae Jung, Boram Park, Sehhoon Park, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 19, 2011
TrkB as a potential synaptic and behavioral tagYuan Lu, Yuanyuan Ji, Sundar Ganesan, et al.
Clinical Lung Cancer|January 27, 2019
Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase InhibitorJiyun Lee, Jong-Mu Sun, Se-Hoon Lee, et al.
Medical Oncology (Northwood, London, England)|July 23, 2016
Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasisSeonggyu Byeon, Jun Soo Ham, Jong-Mu Sun, et al.
Cancer Research and Treatment|July 27, 2019
Clinical Characteristics and Outcomes of Non-small Cell Lung Cancer Patients with HER2 Alterations in KoreaKangkook Lee, Hyun Ae Jung, Jong-Mu Sun, et al.
Biology|October 10, 2020
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|July 14, 2023
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World DataYoungkyung Jeon, Sehhoon Park, Hyun Ae Jung, et al.
Pageof 35